
Strides Pharma Science Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Ennaid Therapeutics partners exclusively with Strides to manufacture life-saving oral Covid-19 Tablet".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Ennaid Therapeutics partners exclusively with Strides to manufacture life-saving oral Covid-19 Tablet".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science